They could do an RO on those still taking leronlim
Post# of 148175
(Total Views: 628)
Posted On: 03/10/2021 12:20:31 AM
They could do an RO on those still taking leronlimab being outside the study timeline it most likely wouldn't be judged as evidence. No longer on leronlimab would be useless unless they restarted on leronlimab but still not evidential.
Why the FDA think's RO is of utmost importance rather than efficacy seems like a boondoggle.
Why the FDA think's RO is of utmost importance rather than efficacy seems like a boondoggle.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼